Back in May, the U.S. Securities and Exchange Commission gave Nasdaq PHLX the green light to launch cash-settled bitcoin index options under the ticker QBTC. The product tracks the CME CF Bitcoin Real Time Index, trades European-style — meaning it can only be exercised at expiration — and was pitched as a hedging tool for spot bitcoin ETF holders right on a securities exchange.
Then, on July 29, CME Group stepped in. The exchange filed a formal petition asking the full SEC Commission to overturn the May approval. Its argument: bitcoin is a commodity, not a security, so options tied to it fall under the exclusive jurisdiction of the Commodity Futures Trading Commission, not the SEC. If CME wins, Nasdaq would need to either register as a CFTC-regulated venue or redesign the contracts around something like a spot ETF instead.
CME isn't a neutral bystander here — it already runs its own regulated bitcoin futures and options and clearly doesn't want a securities-exchange rival muscling into the same business. In its petition, CME warned that letting the approval stand could set a precedent for securities exchanges to list derivatives on any commodity, from gold to oil, without ever going through the CFTC.
The SEC hasn't taken a side. It simply froze the QBTC launch while the full Commission reviews the dispute. Interested parties can submit written comments for or against the approval through August 24, after which regulators will decide whether to keep it, tweak it, or scrap it entirely.
The fight is a reminder that years after spot bitcoin ETFs launched in the U.S., regulators still haven't settled who actually oversees crypto derivatives. Until SEC and CFTC sort it out, ETF holders looking to hedge their exposure will just have to wait — and the market gets another lesson in how unresolved crypto regulation still is.
